Development of and Recovery from Secondary Hypogonadism in Aging Men Prospective Results from the EMAS /

CONTEXT: Secondary hypogonadism is common in aging men; its natural history and predisposing factors are unclear. OBJECTIVES: The objectives were 1) to identify factors that predispose eugonadal men (T >/= 10.5 nmol/L) to develop biochemical secondary hypogonadism (T < 10.5 nmol/L; LH </=...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Rastrelli Giulia
Carter Emma L.
Ahern Tomas
Finn Joseph D.
Antonio Leen
O’Neill Terence W.
Bártfai György
Casanueva Felipe F.
Forti Gianni
Keevil Brian
Maggi Mario
Giwercman Aleksander
Han Thang S.
Földesi Imre
EMAS Study Group
Dokumentumtípus: Cikk
Megjelent: Endocrine Society Press 2015
Sorozat:JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 100 No. 8
doi:10.1210/jc.2015-1571

mtmt:3012126
Online Access:http://publicatio.bibl.u-szeged.hu/8367
Leíró adatok
Tartalmi kivonat:CONTEXT: Secondary hypogonadism is common in aging men; its natural history and predisposing factors are unclear. OBJECTIVES: The objectives were 1) to identify factors that predispose eugonadal men (T >/= 10.5 nmol/L) to develop biochemical secondary hypogonadism (T < 10.5 nmol/L; LH </= 9.4 U/L) and secondary hypogonadal men to recover to eugonadism; and 2) to characterize clinical features associated with these transitions. DESIGN: The study was designed as a prospective observational general population cohort survey. SETTING: The setting was clinical research centers. PARTICIPANTS: The participants were 3369 community-dwelling men aged 40-79 years in eight European centers. INTERVENTION: Interventions included observational follow-up of 4.3 years. MAIN OUTCOME MEASURE: Subjects were categorized according to change/no change in biochemical gonadal status during follow-up as follows: persistent eugonadal (n = 1909), incident secondary hypogonadal (n = 140), persistent secondary hypogonadal (n = 123), and recovered from secondary hypogonadism to eugonadism (n = 96). Baseline predictors and changes in clinical features associated with incident secondary hypogonadism and recovery from secondary hypogonadism were analyzed by regression models. RESULTS: The incidence of secondary hypogonadism was 155.9/10 000/year, whereas 42.9% of men with secondary hypogonadism recovered to eugonadism. Incident secondary hypogonadism was predicted by obesity (body mass index >/= 30 kg/m(2); odds ratio [OR] = 2.86 [95% confidence interval, 1.67; 4.90]; P < .0001), weight gain (OR = 1.79 [1.15; 2.80]; P = .011), and increased waist circumference (OR = 1.73 [1.07; 2.81], P = .026; and OR = 2.64 [1.66; 4.21], P < .0001, for waist circumference 94-102 and >/=102 cm, respectively). Incident secondary hypogonadal men experienced new/worsening sexual symptoms (low libido, erectile dysfunction, and infrequent spontaneous erections). Recovery from secondary hypogonadism was predicted by nonobesity (OR = 2.28 [1.21; 4.31]; P = .011), weight loss (OR = 2.24 [1.04; 4.85]; P = .042), normal waist circumference (OR = 1.93 [1.01; 3.70]; P = .048), younger age (< 60 y; OR = 2.32 [1.12; 4.82]; P = .024), and higher education (OR = 2.11 [1.05; 4.26]; P = .037), but symptoms did not show significant concurrent improvement. CONCLUSION: Obesity-related metabolic and lifestyle factors predispose older men to the development of secondary hypogonadism, which is frequently reversible with weight loss.
Terjedelem/Fizikai jellemzők:3172-3182
ISSN:0021-972X